A Phase I/II Study of Taxotere [docetaxel], Oxaliplatin, and 5- Fluorouracil.
Phase of Trial: Phase I/II
Latest Information Update: 02 Nov 2018
At a glance
- Drugs Docetaxel; Fluorouracil; Oxaliplatin
- Indications Gastric cancer; Oesophageal cancer; Solid tumours
- Focus Adverse reactions; Therapeutic Use
- 15 Oct 2018 Status changed from active, no longer recruiting to completed.
- 31 Aug 2018 Biomarkers information updated
- 21 Nov 2017 Planned End Date changed from 1 Dec 2018 to 1 Dec 2019.